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redicting conservedepitopes in the variants of amastinprotein
f Leishmania major and designig an epitope based immuno-
enic DNA vaccine
. Slathia ∗, P. Sharma
Shri Mata Vaishno Devi University, Katra, Jammu and Kashmir, India
Background: Efforts for designing vaccines against leishmani-
sis are of immense importance because of increasing resistance
o the current drugs and lack of any vaccine against the parasite.
mastin one of the major proteins expressed in amastigote stage
as been shown to be as an important vaccine candidate. In the post
enomicera sequencedata is availableand thismaybeexploited for
esigningepitopebasedvaccines. Thepresent studydealswithpre-
iction of conserved epitopes in the variants of amastin protein in
eishmaniamajor and utilizing them for designing an immunogenic
NA vaccine.
Methods: Almost all amastin (83) sequences of Leishmania
ajor available in the NCBI protein database were aligned using
lustalW tool of DNASTAR 8 software module. The bootstrapping
f phylogenetic tree was done by MegAlign software. Conserved
egions having a length of more than 9 amino acid residues were
sed for prediction ofMHC binding epitopes. NetMHCPan and IEDB
ervers were used for predictions and the predicted epitopes were
oined in tandem and reverse translated using EMBOSS server. The
everse translated sequences were subjected to CpG optimization
y DynaVacs server. This sequence was conceptually cloned in pBI-
MV vector.
Results: Multiple sequence alignment did not show any con-
erved regions thatmaybepresent in all the83 sequences therefore
he sequenceswhich formedapart of similarnodewereused toﬁnd
onserved peptides. The conserved peptides of each node when
sed for prediction resulted in maximum of 7 epitopes for MHC I
nd 6 epitopes for MHC II whereas a minimum of 1 epitope in both
HC I and MHC II. BLAST was used to remove any self epitopes
howing homology to human proteins and any such epitope was
iscarded. The peptide properties were analysed by Protfun server,
xPasy tools and Protean module of DNASTAR 8. DNA sequence
btainedby reverse translation shouldbeoptimized forCpG islands
s theyhavean important role toplay in immunogenicity. Sequence
anipulation to construct plasmid vector resulted in development
f an effective DNA Vaccine.
Conclusion: The DNA vaccine designed using the reverse vacci-
ology approachdescribed abovemayprovide long term immunity
gainst cutaneous leishmaniasis.
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Background: Streptococcus pneumoniae is an important
pathogen accounting for signiﬁcant morbidity and mortality
worldwide. At present, 92 immunologicaly distinct serotypes of
S. pneumoniae have been described, each varying in the structure
of their polysaccharide capsule. To predict potential beneﬁt of
7-, 10- and 13-conjugate vaccines (PCV), we evaluated serotype
distribution, serotype coverage over S. pneumoniae and drug
susceptibility. 7-PCV contains 4-6B-9V-14-18C-19F-23F. 10-PCV is
7-PCV plus 1-5-7F. 13-PCV is 10-PCV plus 3-6A-19A.
Methods: The serotypes of 55 S. pneumoniae isolates from nor-
mally sterile sites obtained from different patients admitted to the
hospitals with invasive diseases (from 17 hospitals) were evalu-
ated. The catchment area was 5 provinces. They were serotyped by
Quellung reaction, using various speciﬁc group and factor antisera
of Pneumotestâ kit, a phase contrastmicroscope and tested for drug
susceptibility by Etest/disk diffusion methods.
Results: The male:female ratio was 1.89: 1. The age range was
2 mo-87 yr. The specimen sources were 48 blood (87.27%), 3 CSF
(5.45%), 3 pleural ﬂuid (5.45%), 1 abdominal cavity (1.83%). The
serotype coverages of 7-, 10-, 13-valent PCV were 46.15%, 53.85%,
84.15% in children<5 yr (n =26) and 51.95%, 59.26%, 74.07% in
adults 15-87 yr (n =27). Three most common serotypes in children
were 6B (26.92%), 19A (19.23%), 14 (11.54%) and adults were 6B
(22.22%), 6A (11.11%), 7F, 18C, 23F (7.41% each). Overall, S. pneu-
moniae was sensitive to penicillin (94.29%), cefotaxime (97.14%),
chloramphenicol (71.43%), clindamycin (66.67%), co-trimoxazole
(22.22%), erythromycin (60%), linezolid (100%), oﬂoxacin (100%),
tetracycline (42.86%) and vancomycin (100%).
Conclusion: The information from this studymay guide vaccine
developement and the decision for the use of pneumococcal vac-with invasive pneumococcal disease in Thailand.
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